Immunome to begin human testing of experimental Covid-19 'cocktail' after FDA lifts clinical hold
March 11, 2022 at 09:57 AM EST
Immunome's IMM-BCP-01 antibody cocktail contains three monoclonal antibodies that target Covid-19.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |